ANTIBACTERIAL ACTIVITY OF CEFCANEL

被引：1

作者：

BERGAN, T ^{[1
]}

DAFONSECA, J ^{[1
]}

机构：

[1] UNIV OSLO,INST PHARM,DEPT MICROBIOL,OSLO 3,NORWAY

来源：

CHEMOTHERAPY | 1993年 / 39卷 / 02期

关键词：

CEPHALOSPORINS; ENTEROBACTERIACEAE; STREPTOCOCCUS; ANTIBIOTICS; SUSCEPTIBILITY; PSEUDOMONAS; HAEMOPHILUS; CEFCANEL;

D O I：

10.1159/000239109

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The minimum inhibitory concentration of cefcanel, a new oral cephalosporin, has been determined for 182 clinical isolates, of which 84 were from the family Enterobacteriaceae, 45 were from the genus Streptococcus, 18 were nonfermentative rods, 25 were Haemophilus influenzae and 10 were Branhamella catarrhalis. In general, cefcanel was more active than the other cephalosporins against the species Escherichia coli, Klebsiella aerogenes and Proteus mirabilis. Among the genus Streptococcus only the enterococci were resistant to cefcanel. H. influenzae and B. catarrhalis showed also a reasonable susceptibility towards cefcanel. Oxidative rods were highly resistant to cefcanel.

引用

页码：96 / 104

页数：9

共 50 条

[1] EFFICACY OF CEFCANEL ON STAPHYLOCOCCI
BERGAN, T
DAFONSECA, J
CHEMOTHERAPY, 1991, 37 (01) : 43 - 49
[2] ANTIBACTERIAL ACTIVITY OF CEFEPIME IN-VITRO
LIU, YC
HUANG, WK
CHENG, DL
CHEMOTHERAPY, 1994, 40 (06) : 384 - 390
[3] Synthesis and antibacterial activity of catecholate-ciprofloxacin conjugates
Fardeau, Sylvain
Dassonville-Klimpt, Alexandra
Audic, Nicolas
Sasaki, Andre
Pillon, Marine
Baudrin, Emmanuel
Mullie, Catherine
Sonnet, Pascal
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (15) : 4049 - 4060
[4] Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety
Cohen, Frederick
Aggen, James B.
Andrews, Logan D.
Assar, Zahra
Boggs, Jen
Choi, Taylor
Dozzo, Paola
Easterday, Ashton N.
Haglund, Cat M.
Hildebrandt, Darin J.
Holt, Melissa C.
Joly, Kristin
Jubb, Adrian
Kamal, Zeeshan
Kane, Timothy R.
Konradi, Andrei W.
Krause, Kevin M.
Linsell, Martin S.
Machajewski, Timothy D.
Miroshnikova, Olga
Moser, Heinz E.
Nieto, Vincent
Thu Phan
Plato, Craig
Serio, Alisa W.
Seroogy, Julie
Shakhmin, Anton
Stein, Adam J.
Sun, Alex D.
Sviridov, Serguei
Wang, Zhan
Wlasichuk, Kenneth
Yang, Wen
Zhou, Xiaoming
Zhu, Hai
Cirz, Ryan T.
CHEMMEDCHEM, 2019, 14 (16) : 1560 - 1572
[5] Labradorins with Antibacterial Activity Produced by Pseudomonas sp.
Broberg, Anders
Bjerketorp, Joakim
Andersson, Pierre
Sahlberg, Christer
Levenfors, Jolanta J.
MOLECULES, 2017, 22 (07):
[6] Development of antibacterial peptides with efficient antibacterial activity, low toxicity, high membrane disruptive activity and a synergistic antibacterial effect
Wang, Hao
Niu, Mingcong
Xue, Tong
Ma, Linhao
Gu, Xiulian
Wei, Guangcheng
Li, Fengqiao
Wang, Chunhua
JOURNAL OF MATERIALS CHEMISTRY B, 2022, 10 (11) : 1858 - 1874
[7] Synthesis and antibacterial activity of 1,8-naphthyridine cephalosporins
Park, JK
Im, SK
Ju, H
Jeon, JM
Kim, CG
Kim, DU
Yoo, JC
Cho, SS
Cho, SK
BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2005, 26 (03): : 371 - 372
[8] Investigation of the antibacterial activity of pioglitazone
Masadeh, Majed M.
Mhaidat, Nizar M.
Al-Azzam, Sayer I.
Alzoubi, Karem H.
DRUG DESIGN DEVELOPMENT AND THERAPY, 2011, 5 : 421 - 425
[9] Optical control of antibacterial activity
Velema, Willem A.
van der Berg, Jan Pieter
Hansen, Mickel J.
Szymanski, Wiktor
Driessen, Arnold J. M.
Feringa, Ben L.
NATURE CHEMISTRY, 2013, 5 (11) : 924 - 928
[10] In vitro and in vivo antibacterial activity of modithromycin against streptococci and Haemophilus influenzae
Sato, Takafumi
Kawai, Yui
Matsuda, Hayato
Tateda, Kazuhiro
Kimura, Soichiro
Ishii, Yoshikazu
Yamaguchi, Keizo
Gotoh, Naomasa
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (07) : 1547 - 1554

← 1 2 3 4 5 →